The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC)
investigates tumors from a proteogenomic perspective, creating rich multi-omics datasets …

Renal cell carcinoma (RCC) is a highly vascularized tumor and prone to distant metastasis.
Sorafenib is the first targeted multikinase inhibitor and first-line chemical drug approved for …

To explore the biology of lung adenocarcinoma (LUAD) and identify new therapeutic
opportunities, we performed comprehensive proteogenomic characterization of 110 tumors and …

Recent progress on visual question answering has explored the merits of grid features for
vision language tasks. Meanwhile, transformer-based models have shown remarkable …

Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few
therapeutic options. We characterized the proteogenomic landscape of LSCC, providing a …

Descriptive region features extracted by object detection networks have played an important
role in the recent advancements of image captioning. However, they are still criticized for …

To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma (ccRCC),
we performed comprehensive genomic, epigenomic, transcriptomic, proteomic, and …

Glioblastoma (GBM) is the most aggressive nervous system cancer. Understanding its
molecular pathogenesis is crucial to improving diagnosis and treatment. Integrated analysis of …

We present a proteogenomic study of 108 human papilloma virus (HPV)-negative head and
neck squamous cell carcinomas (HNSCCs). Proteomic analysis systematically catalogs …

We undertook a comprehensive proteogenomic characterization of 95 prospectively collected
endometrial carcinomas, comprising 83 endometrioid and 12 serous tumors. This analysis …